Back to search

Article

A CRISPR-based SARS-CoV-2 diagnostic assay that is robust against viral evolution and RNA editing

2020-07-03

Abstract excerpt

Extensive testing is essential to break the transmission of the new coronavirus SARS-CoV-2, which causes the ongoing COVID-19 pandemic. Recently, CRISPR-based diagnostics have emerged as attractive alternatives to quantitative real-time PCR due to their faster turnaround time and their potential to be used in point-of-care testing scenarios. However, existing CRISPR-based assays for COVID-19 have not considered vi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7cd3a5ba-92d8-55b2-a69d-6c3c64ad5036
DOI
10.1101/2020.07.03.185850
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A CRISPR-based SARS-CoV-2 diagnostic assay that is robust against viral evolution and RNA editingDOI 10.1101/2020.07.03.185850
Select a neighboring publication to make it the new centre.